Development of alkylating agent-resistan
β
Beverly A. Teicher; Emil Frei
π
Article
π
1988
π
Springer
π
English
β 785 KB
Survival curves and dose escalation studies of four representative human tumor cell lines exposed to the various alkylating agents are presented. With HN2, at a level of one log of cell kill there was a fivefold range in drug concentration required to achieve this degree of cell kill among the cell